Why Has A Drug Safety Alert Been Issued On Mefenamic Acid? Know Everything
A drug safety alert was issued on November 30 because a preliminary analysis conducted by the Pharmacovigilance Programme of India (PvPI), an organisation which identifies drug safety problems, revealed some adverse drug reactions caused by mefenamic acid.
Source : Getty
The Indian Pharmacopoeia Commission under the Union Ministry of Health & Family Welfare has issued a drug safety alert on mefenamic acid, a medicine sold under the brand name Meftal.
Meftal Drug Safety Alert: The Indian Pharmacopoeia Commission under the Union Ministry of Health & Family Welfare has issued a drug safety alert on mefenamic acid, a medicine sold under the brand name Meftal. The drug safety alert was issued on November 30, 2023, because a preliminary analysis conducted by the Pharmacovigilance Programme of India (PvPI), an Indian government organisation which identifies and responds to drug safety problems, revealed some adverse drug reactions caused by
Related Articles
World
Jamaat’s Borderland Breakthrough: Why Polarisation In West Bengal Will Intensify Before & After 2026 Assembly Poll
India
OPINION | Partners Or Rivals? The Calculated Choreography Of China-India Strategic Dialogue
India
OPINION | Indian Military In Quantum Technology Era
India
OPINION | 50 Navies, One Message: India Is Signalling Who Guards The Indo Pacific Seas
India
Crumbling Empires: Civic Poll Debacle Pushes Thackeray And Pawar Families Toward Political Oblivion
India
ABP Live Northeast Narrative | Why Hagrama's Message To PM Modi Didn't Sound Like Politics-As-Usual